ArticlePediatric transplantation2014

A trial of alemtuzumab adjunctive therapy in allogeneic hematopoietic cell transplantation with minimal conditioning for severe combined immunodeficiency.

Christopher C Dvorak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.